Age/Sex group | Number of NADM | Standardized Incidence ratios (95% CI) | |
---|---|---|---|
Actual | Expecteda | ||
All NADMs | |||
 20–39/Male | 20 | 3.69 | 5.42 (3.31,8.38) |
 20–39/Female | 3 | 1.88 | 1.60 (0.33, 4.66) |
 40–59/Male | 80 | 37.58 | 2.13 (1.69,2.65) |
 40–59/Female | 11 | 6.92 | 1.59 (0.79, 2.85) |
 60–79/Male | 29 | 19.40 | 1.49 (1.00,2.15) |
 60–79/Female | 2 | 1.31 | 1.53 (0.18, 5.52) |
 Total | 145 | 70.78 | 2.05 (1.73, 2.41) |
Lung Cancer | |||
 20–39/Male | 1 | 0.06 | 16.55 (0.42, 92.21) |
 20–39/Female | 0 | 0.03 | 0 (0, 118.43) |
 40–59/Male | 14 | 4.16 | 3.37 (1.84, 5.65) |
 40–59/Female | 4 | 0.63 | 6.37 (1.74, 16.31) |
 60–79/Male | 11 | 2.90 | 3.80 (1.90, 6.79) |
 60–79/Female | 0 | 0.24 | 0 (0, 15.55) |
 Total | 30 | 8.02 | 3.74 (2.52, 5.34) |
Anal Cancer | |||
 20–39/Male | 5 | 0.08 | 64.55 (20.98, 150.66) |
 20–39/Female | 0 | 0.005 | 0 (0, 749.71) |
 40–59/Male | 21 | 2.50 | 8.39 (5.19, 12.82) |
 40–59/Female | 1 | 0.26 | 3.82 (0.10, 21.29) |
 60–79/Male | 2 | 0.99 | 2.02 (0.24, 7.30) |
 60–79/Female | 0 | 0.05 | 0 (0, 69.03) |
 Total | 29 | 3.89 | 7.46 (4.99, 10.70) |